Executive Director, U.S. Oncology Marketing, New Asset/ Alliance

Job Description

Our U.S. Oncology business is a growing and dynamic part of our company.  We are currently seeking qualified candidates for the role of Executive Director, U.S. Oncology Marketing, New Asset/ Alliance.  This alliance is focused on the commercialization of a novel individualized neoantigen therapy, currently in Phase III clinical development in multiple tumor types. 

We are seeking an experienced and strategic leader to lead the U.S. Oncology Marketing Team and to serve as the U.S. representative to the alliance commercialization committee.  This role is responsible for leading marketing and cross-functional teams within our company, with support from Alliance company, to set the vision, objectives, priorities, and tactical plans for successful commercialization (pre-launch, launch, and in-line), and for partnering with all support and execution teams in U.S. Oncology for implementation of the alliance agreed to Commercialization Plan. This position requires strong marketing and commercial leadership, the ability to manage multiple stakeholders, and a good understanding of P&L management.

This position will be based in Upper Gwynedd, PA and will report to the Associate Vice President, U.S. Oncology Marketing, Skin and GI/MSI-H Cancers.

The commercial planning and marketing pf V940 is unlike any other product on the market at this time. V940 is being commercialized by our company in partnership with Alliance company through a co-promotional arrangement, and thus carrying the nuances of an alliance as well as the unique product specific requirements. V940 is a product where the manufacturing process is the product, and each patient will receive a unique, individualized version of the therapy.

The marketing strategy and plans of V940 must account for an end-to-end seamless customer journey beginning with appropriate patient identification and acquisition of a patient tumor and blood sample, genetic sequencing of the samples, customized manufacturing of the individualized therapy and subsequent delivery back to the health care provider for administration to the patient. Developing and implementing the steps to enable this journey to flow optimally will require an extraordinary level of integrated planning and execution.

V940 is expected to have an initial launch in melanoma, and is being investigated for future indications in NSCLC, CSCC, RCC, and UC.

Desired skills and experiences the successful candidate will need:

• Strong marketing and commercial leadership experience with a good understanding of P&L management

• Ability to work in “white space” and successfully shape new approaches with cross-functional teams

• Experience managing an alliance or ability to come up to speed quickly with leading in an alliance structure

• Experience in developing commercialization strategies for cell therapies or similar medicines involving complex logistics and patient-specific manufacturing and distribution

• Ability to manage effectively in multi-layered leadership structures and to lead across complex cross-functional teams

• Strong balance of strategic thinking and execution

• High emotional intelligence and interpersonal skills, including grace under pressure and adaptability to other organizational cultures and ways of working

• Experience in building and nurturing large high-performing teams and practicing situational leadership

• Ability to navigate and drive change in the business and teams

• Strong background in executing and succeeding in competitive settings

• Experience with lifecycle management strategies and resourcing dynamics

• Experience in marketing forecasting for oncology products, including market size, class, and brand shares for various indications, competitors, and market events

• Understanding of the role of precision medicine in oncology, including testing and genetic sequencing processes

• Budget management and optimization of resources to maximize return on investment and channel mix.

• Lead and coordinate all marketing activities for new product (V940) in collaboration with alliance partner

• Lead integrated launch planning activities across broad set of cross-functional areas including global marketing, OCAR, IAM, supply chain and distribution, precision medicine, COLT, legal and compliance.

• Serve as primary internal decision point on commercialization choices

• Ensure appropriate implementation of Co-Promotion Agreement (CPA) with Alliance company

• Lead US forecasting for V940 in partnership with global marketing, finance, and global forecasting

• Present updates to senior leadership and